相关实验视频

Updated: Jun 6, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

针对雄激素受体结合变体的疫苗接种以免疫学上准前列腺癌

Robert D Marek¹, Selena Halabi², Mu-En Wang^1,3

¹Department of Pathology, Duke University, Durham, NC 27710, USA.

|November 26, 2024

概括

一种针对雄激素受体变体7 (AR-V7) 的新型疫苗显示出通过克服免疫抑制和提高治疗效率来对抗前列腺癌的希望,即使使用现有疗法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

雄激素受体 (AR) 信号驱动前列腺癌的进展,但由于AR-V7.7等AR拼接变体,治疗通常会失败.
前列腺癌表现出显著的免疫抑制,限制了当前治疗的有效性,如免疫检查点抑制剂.
针对AR轴的现有疗法和基于PSA的疫苗尚未成为晚期前列腺癌的标准护理.

研究的目的:

开发和评估针对AR-V7拼接变异的疫苗.
研究AR-V7在前列腺癌中介免疫抑制中的作用.
评估AR-V7疫苗与其他治疗结合使用的治疗潜力.

主要方法:

开发一种针对AR-V7.7的疫苗.
在临床前模型中测试疫苗诱导AR-V7特异性免疫和抗瘤反应的能力.
评估AR-V7疫苗接种与恩扎拉胺 (AR抗体) 和抗PD-1免疫检查点抑制的组合.

主要成果:

在AR-V7+癌症模型中,AR-V7疫苗引起了特定的免疫和抗瘤反应.
发现AR-V7表达促进了一个免疫抑制的表型.
AR-V7疫苗与恩扎拉胺的联合治疗抑制了侵略性瘤和改善了生存率.
疫苗接种与抗PD-1治疗相结合,在大多数情况下导致了瘤的完全消除.

结论:

AR信号传递在前列腺癌免疫抑制中起着至关重要的作用.
特定于AR-V7的疫苗代表了前列腺癌的潜在治疗策略.
这些疫苗提供显著的抗瘤反应,即使与雄激素信号传递抑制剂一起使用.

关键词:

受体受体是受体的受体.反对割的抵抗力.免疫检查点抑制抑制免疫检查点抑制免疫抑制免疫抑制前列腺癌是前列腺癌.疫苗,疫苗的使用情况.

更多相关视频

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...